Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory familial disease of the skin. It is characterized by an increased ability to form immunoglobulin E and a tendency to ...

Eczema, or atopic dermatitis, is a skin condition involving inflammation that leads to cracked, dry, itchy skin. Eucrisa and other PDE4 inhibitors work by slowing and stopping the action of an ...

“Atopic dermatitis is not a disease that stays constant,” said Eichenfield, so the longer follow-up is important to understanding prescribing patterns. The patients in this study were younger, with an ...

Researchers found a causal association between insomnia and atopic dermatitis and identified several genetic variations contributing to the association.

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset.

Medically reviewed by Casey Gallagher, MDAtopic dermatitis (the most common type of eczema) causes dry, itchy skin with rough, scaly patches. It affects up to 30% of children and 10% of adults, with ...

A patch test for atopic dermatitis helps identify triggers and confirms diagnosis. Learn about self-testing and specialists who perform testing.

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to social stress. In socially active adults, the disease often becomes chronic.

Atopic dermatitis (also known as atopic eczema) is a chronic inflammatory skin disease that is characterised by intense itching and recurrent eczematous lesions. Although it most often starts in ...

Atopic dermatitis (eczema) is a chronic skin condition that causes dry, itchy red patches to appear on different parts of the body, including the elbows, knees and neck. When atopic dermatitis is ...

While eczema does involve the immune system, most scientists wouldn’t classify eczema as an autoimmune disease. Autoimmune ...

Eli Lilly and Co.’s Ebglyss (lebrikizumab) will be the latest U.S. entrant in the increasingly competitive atopic dermatitis space, following FDA approval of the IL-13-targeting antibody for use in ...